Antibodies to PfEMP1 Domains Inhibit Malaria Rosetting
Author Information
Author(s): Ghumra Ashfaq, Khunrae Pongsak, Ataide Ricardo, Raza Ahmed, Rogerson Stephen J., Higgins Matthew K., Rowe J. Alexandra
Primary Institution: Centre for Immunity, Infection and Evolution, Institute of Immunology and Infection Research, School of Biological Sciences, University of Edinburgh
Hypothesis
Can immunization with recombinant PfEMP1 domains generate antibodies that inhibit rosetting and promote phagocytosis of Plasmodium falciparum-infected erythrocytes?
Conclusion
The study shows that antibodies generated against recombinant PfEMP1 domains can effectively inhibit rosetting and promote phagocytosis of infected erythrocytes.
Supporting Evidence
- Antibodies to all PfEMP1 domains recognized the surface of live infected erythrocytes.
- Antibodies to the N-terminal region were the most effective in inhibiting rosetting.
- All antibodies were specific for the R29 parasite strain.
- Antibodies to multiple domains of PfEMP1 inhibited rosetting.
Takeaway
Scientists made a vaccine that helps the body fight malaria by stopping infected blood cells from sticking together and helping to clear them out.
Methodology
Rabbits were immunized with recombinant PfEMP1 proteins, and their antibodies were tested for rosette inhibition and phagocytosis induction.
Limitations
The antibodies generated were strain-specific and did not show cross-reactivity with other P. falciparum strains.
Participant Demographics
Rabbits were used for immunization and antibody generation.
Statistical Information
P-Value
0.04
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website